BiotechTube
Home/HanchorBio/Alvin (Ying-Ming) Luk, PhD, MBA, CCRA
A(

Alvin (Ying-Ming) Luk, PhD, MBA, CCRA

President & Chief Medical Officer (CMO)

HanchorBio

Therapeutic Areas

OncologyImmunology

HanchorBio Pipeline

DrugIndicationPhase
HCB101Gastric Cancer (HER2+), HNSCC, CRC, TNBC, SCLCPhase 1b/2a
HCB301Solid Tumors, Hematologic MalignanciesPhase 1
HCB303Solid Tumors, Hematologic MalignanciesPreclinical
HCB206Autoimmune DiseasesPreclinical

Leadership Team at HanchorBio

S(
Scott (Shih-Gao) Liu, PhD
Founder, Chairman & CEO
YC
Yuehua Cong, PhD
Chief Business Officer (CBO)
A(
Alan (Mu-Zeng) Tseng, EMBA
Chief Financial Officer (CFO)
WZ
Wenwu Zhai, MD, PhD
Chief Scientific Officer (CSO) / R&D General Manager
View full HanchorBio profile